Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancerWeihao Li, Junzhong Lin, Lan Jin et al.|Autophagy|2023Cited by 387
TRIM25 regulates oxaliplatin resistance in colorectal cancer by promoting EZH2 stabilitySha Zhou, Zhenlin Hou|Cell Death and Disease|2021Cited by 65
TRIM25 regulates oxaliplatin resistance in colorectal cancer by promoting EZH2 stabilitySha Zhou, Zhenlin Hou|Research Square|2020Cited by 2
TRIM25 Regulates Oxaliplatin Resistance in Colorectal Cancer by Promoting EZH2 StabilitySha Zhou, Zhenlin Hou|Research Square|2020Cited by 2